[ad_1] STOCKHOLM, Oct. 24, 2024 /PRNewswire/ — Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the third quarter 2024 Third Quarter 2024 Total revenue increased 33 per cent, 39 per cent at […]
Tag: Biotechnology
Lifetime Achievement Award, lecanemab and biomarkers in focus at CTAD
[ad_1] STOCKHOLM, Oct. 24, 2024 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) founder Lars Lannfelt will be presented with the Lifetime Achievement Award in Alzheimer’s Disease Therapeutic Research at the Clinical Trials for […]
Novartis ribociclib (Kisqali®) recognized as Category 1 preferred breast cancer adjuvant treatment by NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
[ad_1] Ribociclib (Kisqali) plus aromatase inhibitor (AI) recommended for HR+/HER2- early breast cancer (EBC) node-positive and high-risk node-negative patients, as studied in the NATALEE trial and indicated by the FDA1 Recommendation comes after recent FDA […]
Dos científicos ganan las becas Basil O’Connor March of Dimes para promover el útero artificial para bebés prematuros y la detección de células falciformes para recién nacidos en el África subsahariana USA – español USA – English
[ad_1] ARLINGTON, Va., 23 de octubre de 2024 /PRNewswire-HISPANIC PR WIRE/ — March of Dimes, la organización líder que lucha por la salud de madres y bebés, ha otorgado a dos médicos científicos el Premio […]
The Human Platelet Lysate market is projected to grow by USD 0.011 Million from 2024-2028, driven by AI and the rising prevalence of chronic diseases
[ad_1] NEW YORK, Oct. 23, 2024 /PRNewswire/ — Report on how AI is driving market transformation – The Global Human Platelet Lysate Market size is estimated to grow by USD 0.011 million from 2024-2028, according to Technavio. […]
